ARRS: What types of breast pain need imaging workup?

Referring physicians need a better understanding of what kinds of breast pain...Read more on AuntMinnie.comRelated Reading: ACR releases updated appropriateness criteria Breast pain tends to prompt imaging overuse Cancer: Breast radiation therapy isn't so bad ASTRO: Breast radiation 'less scary' than expected ACR updates Appropriateness Criteria
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

ConclusionsEven if prevention and treatment of OM are not yet clearly defined and recognized in the clinical practice, the study shows how the correct use of anti- mucositis product (accompanied by an appropriate hygienic and dietetic regimen) seems to be effective in the prevention of this pathology, which is the most frequent side effects on patients undergoing chemotherapy.Legal entity responsible for the studyThe authors.FundingHas not received any funding.DisclosureAll authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research
ConclusionsThe study met is primary endpoint with 86% of non-progressive disease at  + 12 months, reduced pain and better functional status. CA in the hands of expert interventional radiologists, should be considered in guidelines as a reasonable treatment option for these pts. CA will soon challenge medical therapy as front-line therapy in the forthcoming randomized trial CRYO DESMO-02.Clinical trial identificationNCT02476305.Legal entity responsible for the studyH ôpitaux Universitaires de Strasbourg.FundingFrench National Cancer Institute (INCa).DisclosureJ. Kurtz: Travel / Accommodation / Expenses: ...
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research
In this study we aimed to elicit the impact of different palliative therapy options on survival in a nationally representative sample of sinonasal cancer patients.MethodsNational Cancer Database 2004 ‐2015 data sets were queried for cases of primary sinonasal cancer (N = 380). Kaplan‐Meier analysis was utilized to determine median overall survival (M‐OS) and overall survival (OS) among the different treatment cohorts (pain management, palliative radiation therapy, palliative chemotherapy, palliative surgery, and combination therapy). Prognostic factors were elicited by comparing OS by log‐rank tests and subsequent ...
Source: International Forum of Allergy and Rhinology - Category: Allergy & Immunology Authors: Tags: ORIGINAL ARTICLE Source Type: research
We present therapeutic options for bone metastasis using a multidisciplinary approach. Further, we describe future directions for bone metastasis management, focusing on novel bone-specific targeted therapies. PMID: 31456182 [PubMed - in process]
Source: Advances in Experimental Medicine and Biology - Category: Research Tags: Adv Exp Med Biol Source Type: research
Advanced cancer patients have unrecognized gaps in their understanding about palliative radiation therapy (PRT).
Source: Journal of Pain and Symptom Management - Category: Palliative Care Authors: Tags: Brief Report Source Type: research
Advanced cancer patients have unrecognized gaps in their understanding about palliative radiation therapy (PRT).
Source: Journal of Pain and Symptom Management - Category: Palliative Care Authors: Tags: Brief Report Source Type: research
Researchers from Northwestern University have developed a novel way to track how nanoparticles interact with cancer cells and whether they reach their tagets. The team’s work shows that if a nanoparticle targets cancer cells, it undergoes more ...
Source: Medgadget - Category: Medical Devices Authors: Tags: Medicine Nanomedicine Source Type: blogs
Abstract In preclinical studies, selenite had single agent activity and radiosensitized tumors in vivo. Here we report results from a Phase 1 trial in 15 patients with metastatic cancer treated with selenite (5.5 to 49.5 mg) orally as a single dose 2 hours before each radiation therapy (RT) treatment. Patients received RT regimens that were standard of care. The primary objective of the study was to assess the safety of this combination therapy. Secondary objectives included measurement of pharmacokinetics (PK) and evaluation of efficacy. Endpoints included assessment of PK, toxicity, tumor response, and pain befo...
Source: Translational Oncology - Category: Cancer & Oncology Authors: Tags: Transl Oncol Source Type: research
A 70-year-old man presented to the emergency department on a Saturday with complaints of shortness of breath, especially with activity; increased dry cough; and generalized weakness. He denied chest pain or hemoptysis. The patient reported a history of coronary artery disease; coronary artery bypass surgery; and lung cancer treated with surgery, chemotherapy, and radiation therapy. Most recently, he received treatment in his oncologist's office approximately 5  days before. His resting vital signs were as follows: blood pressure 150/54 mm Hg, heart rate 86 beats per minute, temperature 37°C (98.6°F), resp...
Source: Journal of Emergency Nursing: JEN - Category: Nursing Authors: Tags: Clinical Source Type: research
Conclusion SBRT seems to be a safe and effective treatment for adrenal gland metastases in patients whose primary tumor and metastatic spread are controlled by systemic treatment. With a 2-year local control rate of 92.6%, SBRT may be considered as one of the first-line treatments in oligometastatic patients with adrenal metastases.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Pain | Radiation Therapy | Radiology